TriangleNCT00721539 · STUDY IN CONTEXT
Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
Draft scope assessment: narrower. Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm. Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
Read the full study record and all posted results →
Linked outcomes
Complications encountered intraoperatively or up to six weeks postoperatively. This would include injury to patient, hemorrhage, lacerations, and readmission following surgery.
Feasibility Defined as Ability to Perform the Planned Diagnostic or Therapeutic Procedure
Blood lost during procedure
Average operative time in minutes
Reported safety
Quality of life and patient-reported measures
No linked quality-of-life measure is recorded for this setting and study.
Full draft applicability and source-link record
- trial
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- trial label
- Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
- applicability
- narrower
- applicability note
- Linked by condition-string match at the cancer-entity level. The study's eligibility - stage, biomarker, treatment line and prior therapy - has not been reconciled against this page's definition, so its population is narrower than this page in ways not yet recorded. The condition was transformed or resolved through the terminology hierarchy to reach this cancer type, so the link itself is a candidate a reviewer must confirm.
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- provenance class
- registry-condition-search
- discovery note
- Found by searching ClinicalTrials.gov for this cancer type, restricted to studies that have posted results to the registry. No FDA notice, FDA label or NCI summary held by this site cites this study. Because the search asked for posted results, studies without posted results were never looked for, so their absence from this page means nothing.
- outcome Count
- 4
- harms Count
- 1
- qol Count
- 0
- outcomes
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0000
- source section id
- NCT00721539-om-0000
- source outcome index
- 0
- endpoint
- Overall Complication Rate (Intraoperative and Postoperative)
- endpoint definition
- Complications encountered intraoperatively or up to six weeks postoperatively. This would include injury to patient, hemorrhage, lacerations, and readmission following surgery.
- time origin
- Six weeks
- analysis role
- primary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- Subjects enrolled in this pilot study.
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0001
- source section id
- NCT00721539-om-0001
- source outcome index
- 1
- endpoint
- Feasibility Defined as Ability to Perform the Planned Diagnostic or Therapeutic Procedure
- endpoint definition
- Feasibility Defined as Ability to Perform the Planned Diagnostic or Therapeutic Procedure
- time origin
- Six weeks
- analysis role
- secondary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- Adult patients 18 years of age and over
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0002
- source section id
- NCT00721539-om-0002
- source outcome index
- 2
- endpoint
- Average Blood Loss
- endpoint definition
- Blood lost during procedure
- time origin
- Duration of procedure up to two hours
- analysis role
- secondary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- Participants
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0003
- source section id
- NCT00721539-om-0003
- source outcome index
- 3
- endpoint
- Average Operative Time
- endpoint definition
- Average operative time in minutes
- time origin
- Up to four hours (240 minutes)
- analysis role
- secondary
- reporting status
- POSTED
- data cutoff
- Source null
- population note
- Participants
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- arms
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0000
- arm key
- OG000
- arm label
- Transoral Robotic Surgery
- regimen
- Pilot study; single arm - use of da Vinci Surgical Robot Platform to access neoplastic disease of the upper aerodigestive tract. da Vinci Surgical Robot Platform: daVinci Surgical Robot Platform is a surgical device that enhances transoral access to the upper aerodigestive tract through miniaturization of endoscopes and micromanipulators that can be introduced through the mouth. Transoral Robotic Surgery: Eligible patients will undergo transoral treatment of neoplastic disease of the upper aerodigestive tract using the daVinci Surgical Robot Platform as opposed to traditional (TOL - transoral laser; TEC - transoral electrocautery) methods.
- analyzed count
- 9
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT00721539-om-0000#groups/OG000
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0001
- arm key
- OG000
- arm label
- Transoral Robotic Surgery
- regimen
- Pilot study; single arm - use of da Vinci Surgical Robot Platform to access neoplastic disease of the upper aerodigestive tract. da Vinci Surgical Robot Platform: daVinci Surgical Robot Platform is a surgical device that enhances transoral access to the upper aerodigestive tract through miniaturization of endoscopes and micromanipulators that can be introduced through the mouth. Transoral Robotic Surgery: Eligible patients will undergo transoral treatment of neoplastic disease of the upper aerodigestive tract using the daVinci Surgical Robot Platform as opposed to traditional (TOL - transoral laser; TEC - transoral electrocautery) methods.
- analyzed count
- 9
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT00721539-om-0001#groups/OG000
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0002
- arm key
- OG000
- arm label
- Transoral Robotic Surgery
- regimen
- Pilot study; single arm - use of da Vinci Surgical Robot Platform to access neoplastic disease of the upper aerodigestive tract. da Vinci Surgical Robot Platform: daVinci Surgical Robot Platform is a surgical device that enhances transoral access to the upper aerodigestive tract through miniaturization of endoscopes and micromanipulators that can be introduced through the mouth. Transoral Robotic Surgery: Eligible patients will undergo transoral treatment of neoplastic disease of the upper aerodigestive tract using the daVinci Surgical Robot Platform as opposed to traditional (TOL - transoral laser; TEC - transoral electrocautery) methods.
- analyzed count
- 9
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT00721539-om-0002#groups/OG000
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- outcome key
- om-0003
- arm key
- OG000
- arm label
- Transoral Robotic Surgery
- regimen
- Pilot study; single arm - use of da Vinci Surgical Robot Platform to access neoplastic disease of the upper aerodigestive tract. da Vinci Surgical Robot Platform: daVinci Surgical Robot Platform is a surgical device that enhances transoral access to the upper aerodigestive tract through miniaturization of endoscopes and micromanipulators that can be introduced through the mouth. Transoral Robotic Surgery: Eligible patients will undergo transoral treatment of neoplastic disease of the upper aerodigestive tract using the daVinci Surgical Robot Platform as opposed to traditional (TOL - transoral laser; TEC - transoral electrocautery) methods.
- analyzed count
- 9
- analyzed unit
- Participants
- is comparator
- Source null
- source pointer
- NCT00721539-om-0003#groups/OG000
- harms
- release id
- clinical-indications-draft-1
- disease state id
- ds-hypopharyngeal-cancer
- nct id
- NCT00721539
- harm key
- EG000
- source section id
- NCT00721539-ae
- event group key
- EG000
- event group label
- Transoral Robotic Surgery
- serious affected
- 0
- serious at risk
- 9
- other affected
- 0
- other at risk
- 9
- frequency threshold
- 0
- collection period
- Six weeks from the surgical date for each subject
- event definition
- Source null
- undenominated note
- Source null
- curation status
- draft
- reviewed by
- Source null
- reviewed at
- Source null
- created at
- 2026-09-10T00:00:00Z
- quality of life
- setting source links
Preserved source evidence · Not medical advice